证券记录 · 已归档季度
AVBP
ArriVent BioPharma, Inc. · Healthcare · Biotechnology
14被追踪持有人
+1Δ持有人
10.75M持有股份
$198.25M报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +7.7% ·
股份流向 +30.0% ·
净新建仓位 +7.1%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 67 | +6 | 17.31M | $600.66M | +10 | −4 |
| Q1 2026 | 63 | +7 | 15.17M | $349.66M | +10 | −3 |
| Q4 2025 | 56 | +3 | 14.51M | $292.04M | +3 | — |
| Q3 2025 | 14 | +1 | 10.75M | $198.25M | +2 | −1 |
| Q2 2025 | 10 | 0 | 7.02M | $152.80M | +2 | −2 |
| Q1 2025 | 7 | +1 | 1.69M | $31.28M | +2 | −1 |
| Q4 2024 | 6 | -1 | 1.52M | $40.62M | +1 | −2 |
| Q3 2024 | 6 | +4 | 925.82K | $21.76M | +4 | — |
| Q2 2024 | 2 | — | 247.05K | $4.58M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 3.41M | +65.6% | $62.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 3.41M | +65.6% | $62.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 2.05M | +11.3% | $37.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (被动) | 2.03M | +36.8% | $37.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (被动) | 2.03M | +36.8% | $37.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (被动) | 2.03M | +36.8% | $37.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (被动) | 2.03M | +36.8% | $37.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (被动) | 2.03M | +36.8% | $37.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (被动) | 1.03M | +38.7% | $18.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | Geode Capital Management ✦ (被动) | 716.29K | +20.2% | $13.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Geode Capital Management ✦ (被动) | 716.29K | +20.2% | $13.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Goldman Sachs Group ✦ | 431.94K | — | $7.97M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Goldman Sachs Group ✦ | 431.94K | — | $7.97M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 392.02K | — | $7.23M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Millennium Management ✦ | 286.10K | +62.4% | $5.28M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | Marshall Wace ✦ | 180.22K | 新增 | $3.33M | 0.0% | New | 1 | SEC ↗ |
| 33 | Marshall Wace ✦ | 180.22K | 新增 | $3.33M | 0.0% | New | 1 | SEC ↗ |
| 34 | Marshall Wace ✦ | 180.22K | 新增 | $3.33M | 0.0% | New | 1 | SEC ↗ |
| 35 | Two Sigma Investments ✦ | 91.72K | 新增 | $1.69M | 0.0% | New | 1 | SEC ↗ |
| 36 | Wellington Management ✦ | 81.75K | +23.2% | $1.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 37 | Wellington Management ✦ | 81.75K | +23.2% | $1.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 38 | Wellington Management ✦ | 81.75K | +23.2% | $1.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 27.98K | — | $516,268 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 27.98K | — | $516,268 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 27.98K | — | $516,268 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 27.98K | — | $516,268 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 27.98K | — | $516,268 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 27.98K | — | $516,268 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | T. Rowe Price ✦ | 14.36K | +25.3% | $265,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 11.82K | -17.5% | $218,134 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 11.82K | -17.5% | $218,134 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 11.82K | -17.5% | $218,134 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 11.82K | -17.5% | $218,134 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 11.82K | -17.5% | $218,134 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $3.33M | 0.0% |
| Marshall Wace | $3.33M | 0.0% |
| Marshall Wace | $3.33M | 0.0% |
| Two Sigma Investments | $1.69M | 0.0% |
已清仓
| Citadel Advisors | $732,669 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 138 持有人, 42.02M 股份, $965.37M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据